NASDAQ: EPRX
Eupraxia Pharmaceuticals Inc Stock Ownership - Who owns Eupraxia Pharmaceuticals?

Insider buying vs selling

Have Eupraxia Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EPRX insiders and whales buy or sell their stock.

EPRX Shareholders

What type of owners hold Eupraxia Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Scotia Capital Inc4.36%1,552,679$8.31MInstitution
Royal Bank Of Canada0.96%342,828$1.83MInstitution
Td Waterhouse Canada Inc0.29%104,986$561.68kInstitution
Bank Of Montreal0.15%52,250$279.54kInstitution
Ubs Group Ag0.14%51,199$273.91kInstitution
Goldman Sachs Group Inc0.10%34,500$184.58kInstitution
Citadel Advisors LLC0.03%12,054$64.49kInstitution
Raymond James Financial Inc0.03%11,133$59.56kInstitution
Jpmorgan Chase Co0.01%2,700$14.45kInstitution
Bank Of America Corp0.01%2,500$13.38kInstitution

1 of 2

EPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EPRX6.08%0.00%
CTMX56.16%26.97%Net SellingNet Selling
GNFT0.42%0.00%
ALMS61.40%38.60%Net BuyingNet Buying
YMAB62.18%37.82%Net BuyingNet Buying

Eupraxia Pharmaceuticals Stock Ownership FAQ

Who owns Eupraxia Pharmaceuticals?

Eupraxia Pharmaceuticals (NASDAQ: EPRX) is owned by 6.08% institutional shareholders, 0.00% Eupraxia Pharmaceuticals insiders, and 93.92% retail investors. Scotia Capital Inc is the largest individual Eupraxia Pharmaceuticals shareholder, owning 1.55M shares representing 4.36% of the company. Scotia Capital Inc's Eupraxia Pharmaceuticals shares are currently valued at $8.39M.

If you're new to stock investing, here's how to buy Eupraxia Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.